PNRC1 Activators
PNRC1 activators encompass a range of chemicals centered on modulating intracellular signaling cascades, particularly those associated with cAMP, calcium levels, and PKC. Among them, agents that elevate cAMP levels, such as Forskolin, Rolipram, and IBMX, present a strategic approach. The rationale behind this is the known interaction between PNRC1 and nuclear receptors. cAMP elevation can intensify nuclear receptor activity, offering an indirect method to influence PNRC1's function and interaction. The implications of this become evident considering other activators like Cilostamide, Milrinone, and Zardaverine, which, through their inhibition of specific PDEs, also contribute to elevated cAMP, further underscoring the importance of this pathway.
Additionally, calcium signaling represents another critical point of intersection. Agents like Thapsigargin and Ionomycin, which modify intracellular calcium concentrations, can influence nuclear receptor functionalities, indirectly affecting PNRC1's modulation and interactions. PKC, another significant pathway, interacts with PNRC1 and serves as a target for activators such as PMA and OAG. The activation of PKC, especially in the context of its relationship with PNRC1, showcases the intricate ties between these intracellular signaling molecules and the broader role of PNRC1 in cellular functions. Through targeted modulation of these pathways, a nuanced understanding of PNRC1 and its activators becomes apparent.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
cAMP elevator. PNRC1 is known to interact with nuclear receptors. By elevating cAMP levels, Forskolin can enhance the activity of nuclear receptors, which can indirectly modulate PNRC1 activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
PDE4 inhibitor that increases cAMP levels. Elevated cAMP can boost nuclear receptor activity, subsequently influencing the interaction and modulation of PNRC1. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
PDE inhibitor, leading to increased cAMP levels. An upsurge in cAMP can stimulate nuclear receptors, which indirectly affects PNRC1 function and interaction. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
PDE3 inhibitor that leads to increased cAMP levels. Enhancing cAMP levels can promote nuclear receptor functions, thereby indirectly modulating the activity of PNRC1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PKC activator. PNRC1 has been suggested to have interactions with PKC-mediated pathways. Activation of PKC by PMA can indirectly affect PNRC1 function and its downstream effects. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA inhibitor causing increased intracellular calcium levels. Calcium signaling can impact nuclear receptor functions, potentially influencing PNRC1's interactions and modulation. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Calcium ionophore that increases intracellular calcium concentrations. Elevated calcium levels can affect nuclear receptor activities, which may then indirectly modulate PNRC1. | ||||||
1-Oleoyl-2-acetyl-sn-glycerol (OAG) | 86390-77-4 | sc-200417 sc-200417A | 10 mg 50 mg | $119.00 $453.00 | 1 | |
Diacylglycerol analog that can activate PKC. Given the suggested interactions of PNRC1 with PKC pathways, OAG-mediated PKC activation can indirectly modulate PNRC1. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
PDE3 inhibitor resulting in elevated cAMP levels. Higher cAMP concentrations can influence nuclear receptor activities, subsequently affecting PNRC1 function and interaction. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
PDE3 and PDE4 inhibitor, raising cAMP levels. The heightened cAMP can enhance nuclear receptor function, thereby indirectly influencing PNRC1 interactions and activity. | ||||||